{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:59:39Z","timestamp":1792688379395,"version":"4.5.0"},"reference-count":186,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Neurodegenerative and neurovascular disorders affect millions of people worldwide and account for a large and increasing health burden on the general population. Thus, there is a critical need to identify potential disease-modifying treatments that can prevent or slow the disease progression. Mitochondria are highly dynamic organelles and play an important role in energy metabolism and redox homeostasis, and mitochondrial dysfunction threatens cell homeostasis, perturbs energy production, and ultimately leads to cell death and diseases. Impaired mitochondrial function has been linked to the pathogenesis of several human neurological disorders. Given the significant contribution of mitochondrial dysfunction in neurological disorders, there has been considerable interest in developing therapies that can attenuate mitochondrial abnormalities and proffer neuroprotective effects. Unfortunately, therapies that target specific components of mitochondria or oxidative stress pathways have exhibited limited translatability. To this end, mitochondrial transplantation therapy (MTT) presents a new paradigm of therapeutic intervention, which involves the supplementation of healthy mitochondria to replace the damaged mitochondria for the treatment of neurological disorders. Prior studies demonstrated that the supplementation of healthy donor mitochondria to damaged neurons promotes neuronal viability, activity, and neurite growth and has been shown to provide benefits for neural and extra-neural diseases. In this review, we discuss the significance of mitochondria and summarize an overview of the recent advances and development of MTT in neurodegenerative and neurovascular disorders, particularly Parkinson\u2019s disease, Alzheimer\u2019s disease, and stroke. The significance of MTT is emerging as they meet a critical need to develop a disease-modifying intervention for neurodegenerative and neurovascular disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1570159x05666220908100545","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T01:51:46Z","timestamp":1662947506000},"page":"1100-1116","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Therapeutic Potential of Mitochondria Transplantation Therapy in\nNeurodegenerative and Neurovascular Disorders"],"prefix":"10.2174","volume":"21","author":[{"given":"Mohammad Moshahid","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Neurology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, 38163,\nUSA"},{"name":"Neuroscience Institute, University of Tennessee Health Science Center, Memphis, TN, USA"},{"name":"Center for Muscle,\nMetabolism and Neuropathology, Division of Regenerative and Rehabilitation Sciences and Department of Physical\nTherapy, College of Health Professions, University of Tennessee Health Science Center, Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector G.","family":"Paez","sequence":"additional","affiliation":[{"name":"Laboratory of Muscle Biology and Sarcopenia, Department of Physical Therapy, College of Health Professions, University of Tennessee Health Science Center, Memphis, USA"},{"name":"Laboratory of Muscle Biology and Sarcopenia, Department of Physical Therapy, College of Health Professions, University\nof Tennessee Health Science Center, Memphis, TN, USA"},{"name":"Department of Physiology, College of Medicine, University\nof Tennessee Health Science Center, Memphis, TN, USA"},{"name":"Integrated Biomedical Sciences Graduate Program,\nCollege of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, TN, 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Pitzer","sequence":"additional","affiliation":[{"name":"Center for Muscle,\nMetabolism and Neuropathology, Division of Regenerative and Rehabilitation Sciences and Department of Physical\nTherapy, College of Health Professions, University of Tennessee Health Science Center, Memphis, TN, USA"},{"name":"Laboratory of Muscle Biology and Sarcopenia, Department of Physical Therapy, College of Health Professions, University\nof Tennessee Health Science Center, Memphis, TN, USA"},{"name":"Department of Physiology, College of Medicine, University\nof Tennessee Health Science Center, Memphis, TN, USA"},{"name":"Integrated Biomedical Sciences Graduate Program,\nCollege of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, TN, 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Alway","sequence":"additional","affiliation":[{"name":"Center for Muscle,\nMetabolism and Neuropathology, Division of Regenerative and Rehabilitation Sciences and Department of Physical\nTherapy, College of Health Professions, University of Tennessee Health Science Center, Memphis, TN, USA"},{"name":"Laboratory of Muscle Biology and Sarcopenia, Department of Physical Therapy, College of Health Professions, University\nof Tennessee Health Science Center, Memphis, TN, USA"},{"name":"Department of Physiology, College of Medicine, University\nof Tennessee Health Science Center, Memphis, TN, USA"},{"name":"The\nTennessee Institute of Regenerative Medicine, 910 Madison Avenue, Memphis, TN, 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/A:1022642114734","volume":"29","author":"Cooper J.M.","year":"1997","unstructured":"Cooper J.M.; Schapira A.H.V.; Mitochondrial dysfunction in neurodegeneration. J Bioenerg Biomembr 1997,29(2),175-183","journal-title":"J Bioenerg Biomembr"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbadis.2009.10.007","volume":"1802","author":"Moreira P.I.","year":"2010","unstructured":"Moreira P.I.; Zhu X.; Wang X.; Lee H.; Nunomura A.; Petersen R.B.; Perry G.; Smith M.A.; Mitochondria: A therapeutic target in neurodegeneration. Biochim Biophys Acta Mol Basis Dis 2010,1802(1),212-220","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"20704","DOI":"10.3390\/ijms160920704","volume":"16","author":"Luo Y.","year":"2015","unstructured":"Luo Y.; Hoffer A.; Hoffer B.; Qi X.; Mitochondria: A therapeutic target for Parkinson\u2019s Disease? Int J Mol Sci 2015,16(9),20704-20730","journal-title":"Int J Mol Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2019.11.005","volume":"146","author":"He Z.","year":"2020","unstructured":"He Z.; Ning N.; Zhou Q.; Khoshnam S.E.; Farzaneh M.; Mitochondria as a therapeutic target for ischemic stroke. Free Radic Biol Med 2020,146,45-58","journal-title":"Free Radic Biol Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1242\/jcs.099234","volume":"125","author":"Tait S.W.G.","year":"2012","unstructured":"Tait S.W.G.; Green D.R.; Mitochondria and cell signalling. J Cell Sci 2012,125(4),807-815","journal-title":"J Cell Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.beem.2012.05.003","volume":"26","author":"Osellame L.D.","year":"2012","unstructured":"Osellame L.D.; Blacker T.S.; Duchen M.R.; Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab 2012,26(6),711-723","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/1873-3468.12964","volume":"592","author":"Angelova P.R.","year":"2018","unstructured":"Angelova P.R.; Abramov A.Y.; Role of mitochondrial ROS in the brain: From physiology to neurodegeneration. FEBS Lett 2018,592(5),692-702","journal-title":"FEBS Lett"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-020-00107-x","volume":"5","author":"Norat P.","year":"2020","unstructured":"Norat P.; Soldozy S.; Sokolowski J.D.; Gorick C.M.; Kumar J.S.; Chae Y.; Ya\u011fmurlu K.; Prada F.; Walker M.; Levitt M.R.; Price R.J.; Tvrdik P.; Kalani M.Y.S.; Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation. NPJ Regen Med 2020,5(1),22","journal-title":"NPJ Regen Med"},{"key":"ref=9","first-page":"751","volume":"61","author":"Freire M.A.","year":"2012","unstructured":"Freire M.A.; Pathophysiology of neurodegeneration following traumatic brain injury. West Indian Med J 2012,61(7),751-755","journal-title":"West Indian Med J"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","volume":"460","author":"Lau A.","year":"2010","unstructured":"Lau A.; Tymianski M.; Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 2010,460(2),525-542","journal-title":"Pflugers Arch"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"108698","DOI":"10.1016\/j.abb.2020.108698","volume":"702","author":"Johnson J.","year":"2021","unstructured":"Johnson J.; Mercado-Ayon E.; Mercado-Ayon Y.; Dong Y.N.; Halawani S.; Ngaba L.; Lynch D.R.; Mitochondrial dysfunction in the development and progression of neurodegenerative diseases. Arch Biochem Biophys 2021,702,108698","journal-title":"Arch Biochem Biophys"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12264-008-0402-1","volume":"24","author":"Ma Q.","year":"2008","unstructured":"Ma Q.; Beneficial effects of moderate voluntary physical exercise and its biological mechanisms on brain health. Neurosci Bull 2008,24(4),265-270","journal-title":"Neurosci Bull"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.bbr.2016.09.067","volume":"317","author":"Ma C.L.","year":"2017","unstructured":"Ma C.L.; Ma X.T.; Wang J.J.; Liu H.; Chen Y.F.; Yang Y.; Physical exercise induces hippocampal neurogenesis and prevents cognitive decline. Behav Brain Res 2017,317,332-339","journal-title":"Behav Brain Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.21307\/ane-2021-007","volume":"81","author":"Oliveira R.F.","year":"2021","unstructured":"Oliveira R.F.; Paiva K.M.; da Rocha G.S.; de Moura Freire M.A.; de Ara\u00fajo D.P.; de Oliveira L.C.; Guzen F.P.; de Gois Morais P.L.A.; de Paiva Cavalcanti J.R.L.; Neurobiological effects of forced swim exercise on the rodent hippocampus: A systematic review. Acta Neurobiol Exp (Warsz) 2021,81(1),58-68","journal-title":"Acta Neurobiol Exp (Warsz)"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","volume":"5","author":"Zuccato C.","year":"2009","unstructured":"Zuccato C.; Cattaneo E.; Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 2009,5(6),311-322","journal-title":"Nat Rev Neurol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2047-9158-1-14","volume":"1","author":"Weissmiller A.M.","year":"2012","unstructured":"Weissmiller A.M.; Wu C.; Current advances in using neurotrophic factors to treat neurodegenerative disorders. Transl Neurodegener 2012,1(1),14","journal-title":"Transl Neurodegener"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13024-018-0299-8","volume":"13","author":"Cao J.","year":"2018","unstructured":"Cao J.; Hou J.; Ping J.; Cai D.; Advances in developing novel therapeutic strategies for Alzheimer\u2019s disease. Mol Neurodegener 2018,13(1),64","journal-title":"Mol Neurodegener"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/1673-5374.226382","volume":"13","author":"Rabchevsky A.G.","year":"2018","unstructured":"Rabchevsky A.G.; Gollihue J.L.; Patel S.P.; Mitochondrial transplantation strategies as potential therapeutics for central nervous system trauma. Neural Regen Res 2018,13(2),194-197","journal-title":"Neural Regen Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.pmbts.2020.10.001","volume":"177","author":"Mukherjee A.","year":"2021","unstructured":"Mukherjee A.; Becerra C.A.D.; Chavez M.; Delgado J.P.; Soto C.; Mitochondrial transplant to replenish damaged mitochondria: A novel therapeutic strategy for neurodegenerative diseases? Prog Mol Biol Transl Sci 2021,177,49-63","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"113114","DOI":"10.1016\/j.expneurol.2019.113114","volume":"324","author":"Nakamura Y.","year":"2020","unstructured":"Nakamura Y.; Park J.H.; Hayakawa K.; Therapeutic use of extracellular mitochondria in CNS injury and disease. Exp Neurol 2020,324,113114","journal-title":"Exp Neurol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40035-019-0158-8","volume":"8","author":"Chang C.Y.","year":"2019","unstructured":"Chang C.Y.; Liang M.Z.; Chen L.; Current progress of mitochondrial transplantation that promotes neuronal regeneration. Transl Neurodegener 2019,8(1),17","journal-title":"Transl Neurodegener"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1515\/revneuro-2020-0068","volume":"32","author":"Espino De la Fuente-Mu\u00f1oz C.","year":"2021","unstructured":"Espino De la Fuente-Mu\u00f1oz C.; Arias C.; The therapeutic potential of mitochondrial transplantation for the treatment of neurodegenerative disorders. Rev Neurosci 2021,32(2),203-217","journal-title":"Rev Neurosci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.mito.2017.02.005","volume":"34","author":"Shi X.","year":"2017","unstructured":"Shi X.; Zhao M.; Fu C.; Fu A.; Intravenous administration of mitochondria for treating experimental Parkinson\u2019s disease. Mitochondrion 2017,34,91-100","journal-title":"Mitochondrion"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3233\/JAD-190853","volume":"72","author":"Nitzan K.","year":"2019","unstructured":"Nitzan K.; Benhamron S.; Valitsky M.; Kesner E.E.; Lichtenstein M.; Ben-Zvi A.; Ella E.; Segalstein Y.; Saada A.; Lorberboum-Galski H.; Rosenmann H.; Mitochondrial transfer ameliorates cognitive deficits, neuronal loss, and gliosis in Alzheimer\u2019s disease mice. J Alzheimers Dis 2019,72(2),587-604","journal-title":"J Alzheimers Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.7150\/ijbs.40886","volume":"16","author":"Zhao Z.","year":"2020","unstructured":"Zhao Z.; Yu Z.; Hou Y.; Zhang L.; Fu A.; Improvement of cognitive and motor performance with mitotherapy in aged mice. Int J Biol Sci 2020,16(5),849-858","journal-title":"Int J Biol Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.7150\/thno.53474","volume":"11","author":"Alexander J.F.","year":"2021","unstructured":"Alexander J.F.; Seua A.V.; Arroyo L.D.; Ray P.R.; Wangzhou A.; Hei\u00df-L\u00fcckemann L.; Schedlowski M.; Price T.J.; Kavelaars A.; Heijnen C.J.; Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits. Theranostics 2021,11(7),3109-3130","journal-title":"Theranostics"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"10597","DOI":"10.1038\/s41598-021-90094-w","volume":"11","author":"Chang J.C.","year":"2021","unstructured":"Chang J.C.; Chao Y.C.; Chang H.S.; Wu Y.L.; Chang H.J.; Lin Y.S.; Cheng W.L.; Lin T.T.; Liu C.S.; Intranasal delivery of mitochondria for treatment of Parkinson\u2019s Disease model rats lesioned with 6-hydroxydopamine. Sci Rep 2021,11(1),10597","journal-title":"Sci Rep"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jtcvs.2016.10.077","volume":"153","author":"Kaza A.K.","year":"2017","unstructured":"Kaza A.K.; Wamala I.; Friehs I.; Kuebler J.D.; Rathod R.H.; Berra I.; Ericsson M.; Yao R.; Thedsanamoorthy J.K.; Zurakowski D.; Levitsky S.; del Nido P.J.; Cowan D.B.; McCully J.D.; Myocardial rescue with autologous mitochondrial transplantation in a porcine model of ischemia\/reperfusion. J Thorac Cardiovasc Surg 2017,153(4),934-943","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.bbr.2018.09.005","volume":"356","author":"Zhang Z.","year":"2019","unstructured":"Zhang Z.; Ma Z.; Yan C.; Pu K.; Wu M.; Bai J.; Li Y.; Wang Q.; Muscle-derived autologous mitochondrial transplantation: A novel strategy for treating cerebral ischemic injury. Behav Brain Res 2019,356,322-331","journal-title":"Behav Brain Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1111\/jcmm.12316","volume":"18","author":"Kitani T.","year":"2014","unstructured":"Kitani T.; Kami D.; Matoba S.; Gojo S.; Internalization of isolated functional mitochondria: involvement of macropinocytosis. J Cell Mol Med 2014,18(8),1694-1703","journal-title":"J Cell Mol Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.pnpbp.2019.04.010","volume":"93","author":"Wang Y.","year":"2019","unstructured":"Wang Y.; Ni J.; Gao C.; Xie L.; Zhai L.; Cui G.; Yin X.; Mitochondrial transplantation attenuates lipopolysaccharide- induced depression-like behaviors. Prog Neuropsychopharmacol Biol Psychiatry 2019,93,240-249","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.rbmo.2017.01.013","volume":"34","author":"Zhang J.","year":"2017","unstructured":"Zhang J.; Liu H.; Luo S.; Lu Z.; Ch\u00e1vez-Badiola A.; Liu Z.; Yang M.; Merhi Z.; Silber S.J.; Munn\u00e9 S.; Konstantinidis M.; Wells D.; Tang J.J.; Huang T.; Live birth derived from oocyte spindle transfer to prevent mitochondrial disease. Reprod Biomed Online 2017,34(4),361-368","journal-title":"Reprod Biomed Online"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.mito.2017.03.004","volume":"34","author":"McCully J.D.","year":"2017","unstructured":"McCully J.D.; Cowan D.B.; Emani S.M.; del Nido P.J.; Mitochondrial transplantation: From animal models to clinical use in humans. Mitochondrion 2017,34,127-134","journal-title":"Mitochondrion"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"e0160889","DOI":"10.1371\/journal.pone.0160889","volume":"11","author":"Cowan D.B.","year":"2016","unstructured":"Cowan D.B.; Yao R.; Akurathi V.; Snay E.R.; Thedsanamoorthy J.K.; Zurakowski D.; Ericsson M.; Friehs I.; Wu Y.; Levitsky S.; del Nido P.J.; Packard A.B.; McCully J.D.; Intracoronary Delivery of Mitochondria to the Ischemic Heart for Cardioprotection. PLoS One 2016,11(8),e0160889","journal-title":"PLoS One"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jtcvs.2017.02.018","volume":"154","author":"Emani S.M.","year":"2017","unstructured":"Emani S.M.; Piekarski B.L.; Harrild D.; del Nido P.J.; McCully J.D.; Autologous mitochondrial transplantation for dysfunction after ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2017,154(1),286-289","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.3390\/ijms22158312","volume":"22","author":"Valenti D.","year":"2021","unstructured":"Valenti D.; Vacca R.A.; Moro L.; Atlante A.; Mitochondria can cross cell boundaries: An overview of the biological relevance, pathophysiological implications and therapeutic perspectives of intercellular mitochondrial transfer. Int J Mol Sci 2021,22(15),8312","journal-title":"Int J Mol Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1161\/STROKEAHA.117.017758","volume":"48","author":"Chou S.H.Y.","year":"2017","unstructured":"Chou S.H.Y.; Lan J.; Esposito E.; Ning M.; Balaj L.; Ji X.; Lo E.H.; Hayakawa K.; Extracellular mitochondria in cerebrospinal fluid and neurological recovery after subarachnoid hemorrhage. Stroke 2017,48(8),2231-2237","journal-title":"Stroke"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature21695","volume":"543","author":"Ruan L.","year":"2017","unstructured":"Ruan L.; Zhou C.; Jin E.; Kucharavy A.; Zhang Y.; Wen Z.; Florens L.; Li R.; Cytosolic proteostasis through importing of misfolded proteins into mitochondria. Nature 2017,543(7645),443-446","journal-title":"Nature"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fphar.2019.00902","volume":"10","author":"Cenini G.","year":"2019","unstructured":"Cenini G.; Voos W.; Mitochondria as potential targets in Alzheimer disease therapy: an update. Front Pharmacol 2019,10,902","journal-title":"Front Pharmacol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1042\/CS20160002","volume":"130","author":"Aon M.A.","year":"2016","unstructured":"Aon M.A.; Cortassa S.; Juhaszova M.; Sollott S.J.; Mitochondrial health, the epigenome and healthspan. Clin Sci (Lond) 2016,130(15),1285-1305","journal-title":"Clin Sci (Lond)"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"688789","DOI":"10.3389\/fcell.2021.688789","volume":"9","author":"Xu S.","year":"2021","unstructured":"Xu S.; Zhang X.; Liu C.; Liu Q.; Chai H.; Luo Y.; Li S.; Role of mitochondria in neurodegenerative diseases: from an epigenetic perspective. Front Cell Dev Biol 2021,9,688789","journal-title":"Front Cell Dev Biol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature12985","volume":"505","author":"Friedman J.R.","year":"2014","unstructured":"Friedman J.R.; Nunnari J.; Mitochondrial form and function. Nature 2014,505(7483),335-343","journal-title":"Nature"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"7320","DOI":"10.1074\/jbc.M008363200","volume":"276","author":"Slee E.A.","year":"2001","unstructured":"Slee E.A.; Adrain C.; Martin S.J.; Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 2001,276(10),7320-7326","journal-title":"J Biol Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"Tang D.","year":"2019","unstructured":"Tang D.; Kang R.; Berghe T.V.; Vandenabeele P.; Kroemer G.; The molecular machinery of regulated cell death. Cell Res 2019,29(5),347-364","journal-title":"Cell Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1083\/jcb.201312123","volume":"204","author":"Sheng Z.H.","year":"2014","unstructured":"Sheng Z.H.; Mitochondrial trafficking and anchoring in neurons: New insight and implications. J Cell Biol 2014,204(7),1087-1098","journal-title":"J Cell Biol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-018-0487-4","volume":"25","author":"Guan R.","year":"2018","unstructured":"Guan R.; Zou W.; Dai X.; Yu X.; Liu H.; Chen Q.; Teng W.; Mitophagy, a potential therapeutic target for stroke. J Biomed Sci 2018,25(1),87","journal-title":"J Biomed Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.redox.2018.03.002","volume":"16","author":"Yang J.L.","year":"2018","unstructured":"Yang J.L.; Mukda S.; Chen S.D.; Diverse roles of mitochondria in ischemic stroke. Redox Biol 2018,16,263-275","journal-title":"Redox Biol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"687246","DOI":"10.3389\/fnagi.2021.687246","volume":"13","author":"Shen L.","year":"2021","unstructured":"Shen L.; Gan Q.; Yang Y.; Reis C.; Zhang Z.; Xu S.; Zhang T.; Sun C.; Mitophagy in cerebral ischemia and ischemia\/reperfusion injury. Front Aging Neurosci 2021,13,687246","journal-title":"Front Aging Neurosci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JAD-190426","volume":"70","author":"El-Hayek Y.H.","year":"2019","unstructured":"El-Hayek Y.H.; Wiley R.E.; Khoury C.P.; Daya R.P.; Ballard C.; Evans A.R.; Karran M.; Molinuevo J.L.; Norton M.; Atri A.; Tip of the iceberg: assessing the global socioeconomic costs of Alzheimer\u2019s disease and related dementias and strategic implications for stakeholders. J Alzheimers Dis 2019,70(2),323-341","journal-title":"J Alzheimers Dis"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"95-104","DOI":"10.1016\/j.mad.2016.05.005","volume":"161","author":"Abolhassani N","year":"2017","unstructured":"Abolhassani N; Leon J; Sheng Z; Oka S; Hamasaki H; Iwaki T; Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain. Mech Ageing Dev 2017,161(Pt A),95-104","journal-title":"Mech Ageing Dev"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-981-13-3540-2_3","volume":"1128","author":"Nakabeppu Y.","year":"2019","unstructured":"Nakabeppu Y.; Molecular pathophysiology of insulin depletion, mitochondrial dysfunction, and oxidative stress in Alzheimer\u2019s disease brain. Adv Exp Med Biol 2019,1128,27-44","journal-title":"Adv Exp Med Biol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bbadis.2009.10.006","volume":"1802","author":"Moreira P.I.","year":"2010","unstructured":"Moreira P.I.; Carvalho C.; Zhu X.; Smith M.A.; Perry G.; Mitochondrial dysfunction is a trigger of Alzheimer\u2019s disease pathophysiology. Biochim Biophys Acta Mol Basis Dis 2010,1802(1),2-10","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1093\/hmg\/ddy042","volume":"27","author":"Manczak M.","year":"2018","unstructured":"Manczak M.; Kandimalla R.; Yin X.; Reddy P.H.; Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet 2018,27(8),1332-1342","journal-title":"Hum Mol Genet"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"Wang W.","year":"2020","unstructured":"Wang W.; Zhao F.; Ma X.; Perry G.; Zhu X.; Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol Neurodegener 2020,15(1),30","journal-title":"Mol Neurodegener"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","volume":"63","author":"Swerdlow R.H.","year":"2004","unstructured":"Swerdlow R.H.; Khan S.M.A.; \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer\u2019s disease. Med Hypotheses 2004,63(1),8-20","journal-title":"Med Hypotheses"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","volume":"60","author":"Nunomura A.","year":"2001","unstructured":"Nunomura A.; Perry G.; Aliev G.; Hirai K.; Takeda A.; Balraj E.K.; Jones P.K.; Ghanbari H.; Wataya T.; Shimohama S.; Chiba S.; Atwood C.S.; Petersen R.B.; Smith M.A.; Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001,60(8),759-767","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1111\/bph.14585","volume":"176","author":"Perez Ortiz J.M.","year":"2019","unstructured":"Perez Ortiz J.M.; Swerdlow R.H.; Mitochondrial dysfunction in Alzheimer\u2019s disease: Role in pathogenesis and novel therapeutic opportunities. Br J Pharmacol 2019,176(18),3489-3507","journal-title":"Br J Pharmacol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1474-4422(10)70277-5","volume":"10","author":"Kapogiannis D.","year":"2011","unstructured":"Kapogiannis D.; Mattson M.P.; Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer\u2019s disease. Lancet Neurol 2011,10(2),187-198","journal-title":"Lancet Neurol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.exger.2017.07.004","volume":"107","author":"Croteau E.","year":"2018","unstructured":"Croteau E.; Castellano C.A.; Fortier M.; Bocti C.; Fulop T.; Paquet N.; Cunnane S.C.; A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer\u2019s disease. Exp Gerontol 2018,107,18-26","journal-title":"Exp Gerontol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1073\/pnas.2635903100","volume":"101","author":"Reiman E.M.","year":"2004","unstructured":"Reiman E.M.; Chen K.; Alexander G.E.; Caselli R.J.; Bandy D.; Osborne D.; Saunders A.M.; Hardy J.; Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia. Proc Natl Acad Sci USA 2004,101(1),284-289","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"Butterfield D.A.","year":"2019","unstructured":"Butterfield D.A.; Halliwell B.; Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 2019,20(3),148-160","journal-title":"Nat Rev Neurosci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1093\/hmg\/ddy154","volume":"27","author":"Reddy P.H.","year":"2018","unstructured":"Reddy P.H.; Yin X.; Manczak M.; Kumar S.; Pradeepkiran J.A.; Vijayan M.; Reddy A.P.; Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer\u2019s disease. Hum Mol Genet 2018,27(14),2502-2516","journal-title":"Hum Mol Genet"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1093\/hmg\/ddr381","volume":"20","author":"Calkins M.J.","year":"2011","unstructured":"Calkins M.J.; Manczak M.; Mao P.; Shirendeb U.; Reddy P.H.; Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet 2011,20(23),4515-4529","journal-title":"Hum Mol Genet"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"617588","DOI":"10.3389\/fnagi.2021.617588","volume":"13","author":"Misrani A.","year":"2021","unstructured":"Misrani A.; Tabassum S.; Yang L.; Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease. Front Aging Neurosci 2021,13,617588","journal-title":"Front Aging Neurosci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/jpet.112.192138","volume":"342","author":"Johri A.","year":"2012","unstructured":"Johri A.; Beal M.F.; Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther 2012,342(3),619-630","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jprot.2016.03.022","volume":"139","author":"Minjarez B.","year":"2016","unstructured":"Minjarez B.; Calder\u00f3n-Gonz\u00e1lez K.G.; Rustarazo M.L.V.; Herrera-Aguirre M.E.; Labra-Barrios M.L.; Rincon-Limas D.E.; del Pino M.M.S.; Mena R.; Luna-Arias J.P.; Identification of proteins that are differentially expressed in brains with Alzheimer\u2019s disease using iTRAQ labeling and tandem mass spectrometry. J Proteomics 2016,139,103-121","journal-title":"J Proteomics"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0197-4580(00)00112-3","volume":"21","author":"Maurer I.","year":"2000","unstructured":"Maurer I.; Zierz S.; M\u00f6ller H.J.; A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 2000,21(3),455-462","journal-title":"Neurobiol Aging"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","volume":"120","author":"Balaban R.S.","year":"2005","unstructured":"Balaban R.S.; Nemoto S.; Finkel T.; Mitochondria, oxidants, and aging. Cell 2005,120(4),483-495","journal-title":"Cell"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"S469","DOI":"10.3233\/JAD-179912","volume":"64","author":"Butterfield D.A.","year":"2018","unstructured":"Butterfield D.A.; Perspectives on oxidative stress in Alzheimer\u2019s disease and predictions of future research emphases. J Alzheimers Dis 2018,64(s1),S469-S479","journal-title":"J Alzheimers Dis"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"S357","DOI":"10.3233\/JAD-2010-100498","volume":"20","author":"Patten D.A.","year":"2010","unstructured":"Patten D.A.; Germain M.; Kelly M.A.; Slack R.S.; Reactive oxygen species: stuck in the middle of neurodegeneration. J Alzheimers Dis 2010,20(s2)(Suppl. 2),S357-S367","journal-title":"J Alzheimers Dis"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","volume":"147","author":"Jiang T.","year":"2016","unstructured":"Jiang T.; Sun Q.; Chen S.; Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson\u2019s disease and Alzheimer\u2019s disease. Prog Neurobiol 2016,147,1-19","journal-title":"Prog Neurobiol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fnagi.2014.00206","volume":"6","author":"Santos J.R.","year":"2014","unstructured":"Santos J.R.; Gois A.M.; Mendon\u00e7a D.M.; Freire M.A.; Nutritional status, oxidative stress and dementia: the role of selenium in Alzheimer\u2019s disease. Front Aging Neurosci 2014,6,206","journal-title":"Front Aging Neurosci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1136\/jim-2016-000240","volume":"64","author":"Reddy P.H.","year":"2016","unstructured":"Reddy P.H.; Manczak M.; Yin X.; Grady M.C.; Mitchell A.; Kandimalla R.; Kuruva C.S.; Protective effects of a natural product, curcumin, against amyloid \u03b2 induced mitochondrial and synaptic toxicities in Alzheimer\u2019s disease. J Investig Med 2016,64(8),1220-1234","journal-title":"J Investig Med"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2174\/0929867325666180117112610","volume":"17","author":"da Costa I.M.","year":"2019","unstructured":"da Costa I.M.; de Moura Freire M.A.; de Paiva Cavalcanti J.R.L.; de Ara\u00fajo D.P.; Norrara B.; Moreira Rosa I.M.M.; de Azevedo E.P.; do Rego A.C.M.; Filho I.A.; Guzen F.P.; Supplementation with curcuma longa reverses neurotoxic and behavioral damage in models of Alzheimer\u2019s disease: a systematic review. Curr Neuropharmacol 2019,17(5),406-421","journal-title":"Curr Neuropharmacol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/archneurol.2008.588","volume":"66","author":"Qin W.","year":"2009","unstructured":"Qin W.; Haroutunian V.; Katsel P.; Cardozo C.P.; Ho L.; Buxbaum J.D.; Pasinetti G.M.; PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch Neurol 2009,66(3),352-361","journal-title":"Arch Neurol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1471-4159.2011.07581.x","volume":"120","author":"Sheng B.","year":"2012","unstructured":"Sheng B.; Wang X.; Su B.; Lee H.; Casadesus G.; Perry G.; Zhu X.; Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer\u2019s disease. J Neurochem 2012,120(3),419-429","journal-title":"J Neurochem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","volume":"21","author":"Hirai K.","year":"2001","unstructured":"Hirai K.; Aliev G.; Nunomura A.; Fujioka H.; Russell R.L.; Atwood C.S.; Johnson A.B.; Kress Y.; Vinters H.V.; Tabaton M.; Shimohama S.; Cash A.D.; Siedlak S.L.; Harris P.L.R.; Jones P.K.; Petersen R.B.; Perry G.; Smith M.A.; Mitochondrial abnormalities in Alzheimer\u2019s disease. J Neurosci 2001,21(9),3017-3023","journal-title":"J Neurosci"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","volume":"29","author":"Wang X.","year":"2009","unstructured":"Wang X.; Su B.; Lee H.; Li X.; Perry G.; Smith M.A.; Zhu X.; Impaired balance of mitochondrial fission and fusion in Alzheimer\u2019s disease. J Neurosci 2009,29(28),9090-9103","journal-title":"J Neurosci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/175062","volume":"2014","author":"Hroudov\u00e1 J.","year":"2014","unstructured":"Hroudov\u00e1 J.; Singh N.; Fi\u0161ar Z.; Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer\u2019s disease. BioMed Res Int 2014,2014,1-9","journal-title":"BioMed Res Int"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"Fang E.F.","year":"2019","unstructured":"Fang E.F.; Hou Y.; Palikaras K.; Adriaanse B.A.; Kerr J.S.; Yang B.; Lautrup S.; Hasan-Olive M.M.; Caponio D.; Dan X.; Rockt\u00e4schel P.; Croteau D.L.; Akbari M.; Greig N.H.; Fladby T.; Nilsen H.; Cader M.Z.; Mattson M.P.; Tavernarakis N.; Bohr V.A.; Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci 2019,22(3),401-412","journal-title":"Nat Neurosci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/cells9010150","volume":"9","author":"Cai Q.","year":"2020","unstructured":"Cai Q.; Jeong Y.Y.; Mitophagy in Alzheimer\u2019s disease and other age-related neurodegenerative diseases. Cells 2020,9(1),150","journal-title":"Cells"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1038\/s41467-020-19547-6","volume":"11","author":"Cen X.","year":"2020","unstructured":"Cen X.; Chen Y.; Xu X.; Wu R.; He F.; Zhao Q.; Sun Q.; Yi C.; Wu J.; Najafov A.; Xia H.; Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer\u2019s disease mouse model. Nat Commun 2020,11(1),5731","journal-title":"Nat Commun"},{"key":"ref=83","first-page":"504","volume":"40","author":"DeMaagd G.","year":"2015","unstructured":"DeMaagd G.; Philip A.; Parkinson\u2019s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. PandT 2015,40(8),504-532","journal-title":"PandT"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"Surmeier D.J.","year":"2018","unstructured":"Surmeier D.J.; Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J 2018,285(19),3657-3668","journal-title":"FEBS J"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"Bose A.","year":"2016","unstructured":"Bose A.; Beal M.F.; Mitochondrial dysfunction in Parkinson\u2019s disease. J Neurochem 2016,139(Suppl. 1),216-231","journal-title":"J Neurochem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neuint.2018.03.001","volume":"117","author":"Ammal Kaidery N.","year":"2018","unstructured":"Ammal Kaidery N.; Thomas B.; Current perspective of mitochondrial biology in Parkinson\u2019s disease. Neurochem Int 2018,117,91-113","journal-title":"Neurochem Int"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","volume":"40","author":"Ryan B.J.","year":"2015","unstructured":"Ryan B.J.; Hoek S.; Fon E.A.; Wade-Martins R.; Mitochondrial dysfunction and mitophagy in Parkinson\u2019s: from familial to sporadic disease. Trends Biochem Sci 2015,40(4),200-210","journal-title":"Trends Biochem Sci"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1038\/emboj.2012.170","volume":"31","author":"Exner N.","year":"2012","unstructured":"Exner N.; Lutz A.K.; Haass C.; Winklhofer K.F.; Mitochondrial dysfunction in Parkinson\u2019s disease: molecular mechanisms and pathophysiological consequences. EMBO J 2012,31(14),3038-3062","journal-title":"EMBO J"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ana.410300409","volume":"30","author":"Hattori N.","year":"1991","unstructured":"Hattori N.; Tanaka M.; Ozawa T.; Mizuno Y.; Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson\u2019s disease. Ann Neurol 1991,30(4),563-571","journal-title":"Ann Neurol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106-107","author":"Subramaniam S.R.","year":"2013","unstructured":"Subramaniam S.R.; Chesselet M.F.; Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol 2013,106-107,17-32","journal-title":"Prog Neurobiol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.expneurol.2009.03.006","volume":"218","author":"B\u00fceler H.","year":"2009","unstructured":"B\u00fceler H.; Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson\u2019s disease. Exp Neurol 2009,218(2),235-246","journal-title":"Exp Neurol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s12035-014-8893-4","volume":"52","author":"Santos D.","year":"2015","unstructured":"Santos D.; Esteves A.R.; Silva D.F.; Janu\u00e1rio C.; Cardoso S.M.; The impact of mitochondrial fusion and fission modulation in sporadic Parkinson\u2019s disease. Mol Neurobiol 2015,52(1),573-586","journal-title":"Mol Neurobiol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1523\/JNEUROSCI.0541-18.2018","volume":"38","author":"Van Laar V.S.","year":"2018","unstructured":"Van Laar V.S.; Arnold B.; Howlett E.H.; Calderon M.J.; St Croix C.M.; Greenamyre J.T.; Sanders L.H.; Berman S.B.; Evidence for compartmentalized axonal mitochondrial biogenesis: mitochondrial DNA replication increases in distal axons as an early response to Parkinson\u2019s disease-relevant stress. J Neurosci 2018,38(34),7505-7515","journal-title":"J Neurosci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","volume":"2","author":"Zheng B.","year":"2010","unstructured":"Zheng B.; Liao Z.; Locascio J.J.; Lesniak K.A.; Roderick S.S.; Watt M.L.; Eklund A.C.; Zhang-James Y.; Kim P.D.; Hauser M.A.; Gr\u00fcnblatt E.; Moran L.B.; Mandel S.A.; Riederer P.; Miller R.M.; Federoff H.J.; W\u00fcllner U.; Papapetropoulos S.; Youdim M.B.; Cantuti-Castelvetri I.; Young A.B.; Vance J.M.; Davis R.L.; Hedreen J.C.; Adler C.H.; Beach T.G.; Graeber M.B.; Middleton F.A.; Rochet J.C.; Scherzer C.R.; PGC-1\u03b1, a potential therapeutic target for early intervention in Parkinson\u2019s disease. Sci Transl Med 2010,2(52),52ra73","journal-title":"Sci Transl Med"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ng1778","volume":"38","author":"Kraytsberg Y.","year":"2006","unstructured":"Kraytsberg Y.; Kudryavtseva E.; McKee A.C.; Geula C.; Kowall N.W.; Khrapko K.; Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 2006,38(5),518-520","journal-title":"Nat Genet"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","volume":"1189","author":"Parker W.D.","year":"2008","unstructured":"Parker W.D.; Parks J.K.; Swerdlow R.H.; Complex I deficiency in Parkinson\u2019s disease frontal cortex. Brain Res 2008,1189,215-218","journal-title":"Brain Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.ajpath.2013.09.002","volume":"183","author":"Pienaar I.S.","year":"2013","unstructured":"Pienaar I.S.; Elson J.L.; Racca C.; Nelson G.; Turnbull D.M.; Morris C.M.; Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease. Am J Pathol 2013,183(6),1826-1840","journal-title":"Am J Pathol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"a011304","DOI":"10.1101\/cshperspect.a011304","volume":"5","author":"Schwarz T.L.","year":"2013","unstructured":"Schwarz T.L.; Mitochondrial trafficking in neurons. Cold Spring Harb Perspect Biol 2013,5(6),a011304","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/ncpneuro0924","volume":"4","author":"Henchcliffe C.","year":"2008","unstructured":"Henchcliffe C.; Beal M.F.; Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 2008,4(11),600-609","journal-title":"Nat Clin Pract Neurol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"Pickrell A.M.","year":"2015","unstructured":"Pickrell A.M.; Youle R.J.; The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron 2015,85(2),257-273","journal-title":"Neuron"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"R183-94","DOI":"10.1093\/hmg\/ddm159","volume":"16","author":"Thomas B","year":"2007","unstructured":"Thomas B; Beal MF; Parkinson's disease. Hum Mol Genet 2007,16(Spec No. 2),R183-94","journal-title":"Hum Mol Genet"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fneur.2013.00038","volume":"4","author":"Trempe J.F.","year":"2013","unstructured":"Trempe J.F.; Fon E.A.; Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of Neuroprotection. Front Neurol 2013,4,38","journal-title":"Front Neurol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm.3983","volume":"22","author":"Wang W.","year":"2016","unstructured":"Wang W.; Wang X.; Fujioka H.; Hoppel C.; Whone A.L.; Caldwell M.A.; Cullen P.J.; Liu J.; Zhu X.; Parkinson\u2019s disease\u2013associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Nat Med 2016,22(1),54-63","journal-title":"Nat Med"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"249-57","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"Rocha EM","year":"2018","unstructured":"Rocha EM; De Miranda B; Sanders LH; Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease. Neurobiol Dis 2018,109(Pt B),249-57","journal-title":"Neurobiol Dis"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"20710","DOI":"10.1074\/jbc.M110.213538","volume":"286","author":"Nakamura K.","year":"2011","unstructured":"Nakamura K.; Nemani V.M.; Azarbal F.; Skibinski G.; Levy J.M.; Egami K.; Munishkina L.; Zhang J.; Gardner B.; Wakabayashi J.; Sesaki H.; Cheng Y.; Finkbeiner S.; Nussbaum R.L.; Masliah E.; Edwards R.H.; Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem 2011,286(23),20710-20726","journal-title":"J Biol Chem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"6957","DOI":"10.1096\/fj.201802628R","volume":"33","author":"Mallach A.","year":"2019","unstructured":"Mallach A.; Weinert M.; Arthur J.; Gveric D.; Tierney T.S.; Alavian K.N.; Post mortem examination of Parkinson\u2019s disease brains suggests decline in mitochondrial biomass, reversed by deep brain stimulation of subthalamic nucleus. FASEB J 2019,33(6),6957-6961","journal-title":"FASEB J"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm1693","volume":"14","author":"Bekar L.","year":"2008","unstructured":"Bekar L.; Libionka W.; Tian G.F.; Xu Q.; Torres A.; Wang X.; Lovatt D.; Williams E.; Takano T.; Schnermann J.; Bakos R.; Nedergaard M.; Adenosine is crucial for deep brain stimulation\u2013mediated attenuation of tremor. Nat Med 2008,14(1),75-80","journal-title":"Nat Med"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1161\/STROKEAHA.108.543769","volume":"40","author":"Vosler P.S.","year":"2009","unstructured":"Vosler P.S.; Graham S.H.; Wechsler L.R.; Chen J.; Mitochondrial targets for stroke: focusing basic science research toward development of clinically translatable therapeutics. Stroke 2009,40(9),3149-3155","journal-title":"Stroke"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"924","DOI":"10.14336\/AD.2017.1126","volume":"9","author":"Liu F.","year":"2018","unstructured":"Liu F.; Lu J.; Manaenko A.; Tang J.; Hu Q.; Mitochondria in Ischemic Stroke: New Insight and Implications. Aging Dis 2018,9(5),924-937","journal-title":"Aging Dis"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.neuropharm.2008.01.005","volume":"55","author":"Doyle K.P.","year":"2008","unstructured":"Doyle K.P.; Simon R.P.; Stenzel-Poore M.P.; Mechanisms of ischemic brain damage. Neuropharmacology 2008,55(3),310-318","journal-title":"Neuropharmacology"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s10072-017-2938-1","volume":"38","author":"Khoshnam S.E.","year":"2017","unstructured":"Khoshnam S.E.; Winlow W.; Farzaneh M.; Farbood Y.; Moghaddam H.F.; Pathogenic mechanisms following ischemic stroke. Neurol Sci 2017,38(7),1167-1186","journal-title":"Neurol Sci"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10495-021-01661-5","volume":"26","author":"Jia J.","year":"2021","unstructured":"Jia J.; Jin H.; Nan D.; Yu W.; Huang Y.; New insights into targeting mitochondria in ischemic injury. Apoptosis 2021,26(3-4),163-183","journal-title":"Apoptosis"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pneurobio.2016.06.006","volume":"157","author":"Ham P.B.","year":"2017","unstructured":"Ham P.B.; Raju R.; Mitochondrial function in hypoxic ischemic injury and influence of aging. Prog Neurobiol 2017,157,92-116","journal-title":"Prog Neurobiol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1161\/STROKEAHA.108.531632","volume":"40","author":"Broughton B.R.S.","year":"2009","unstructured":"Broughton B.R.S.; Reutens D.C.; Sobey C.G.; Apoptotic mechanisms after cerebral ischemia. Stroke 2009,40(5),e331-e339","journal-title":"Stroke"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1358\/dnp.2003.16.8.829348","volume":"16","author":"Zheng Z.","year":"2003","unstructured":"Zheng Z.; Zhao H.; Steinberg G.K.; Yenari M.A.; Cellular and molecular events underlying ischemia-induced neuronal apoptosis. Drug News Perspect 2003,16(8),497-503","journal-title":"Drug News Perspect"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbadis.2009.09.003","volume":"1802","author":"Sims N.R.","year":"2010","unstructured":"Sims N.R.; Muyderman H.; Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta Mol Basis Dis 2010,1802(1),80-91","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nrm3479","volume":"13","author":"Galluzzi L.","year":"2012","unstructured":"Galluzzi L.; Kepp O.; Kroemer G.; Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol 2012,13(12),780-788","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"7974","DOI":"10.1523\/JNEUROSCI.0897-06.2006","volume":"26","author":"Endo H.","year":"2006","unstructured":"Endo H.; Kamada H.; Nito C.; Nishi T.; Chan P.H.; Mitochondrial translocation of p53 mediates release of cytochrome c and hippocampal CA1 neuronal death after transient global cerebral ischemia in rats. J Neurosci 2006,26(30),7974-7983","journal-title":"J Neurosci"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/S0140-6736(80)91465-8","volume":"315","author":"Hares M.M.","year":"1980","unstructured":"Hares M.M.; Downing R.; Marsh J.; Failure of metronidazole\/penicillin oral prophylaxis to prevent amputation stump infection. Lancet 1980,315(8176),1028-1029","journal-title":"Lancet"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.freeradbiomed.2005.01.019","volume":"38","author":"Crack P.J.","year":"2005","unstructured":"Crack P.J.; Taylor J.M.; Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 2005,38(11),1433-1444","journal-title":"Free Radic Biol Med"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12975-015-0439-1","volume":"7","author":"Dharmasaroja P.A.","year":"2016","unstructured":"Dharmasaroja P.A.; Fluid Intake Related to Brain Edema in Acute Middle Cerebral Artery Infarction. Transl Stroke Res 2016,7(1),49-53","journal-title":"Transl Stroke Res"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1172\/JCI11003","volume":"106","author":"Lee J.M.","year":"2000","unstructured":"Lee J.M.; Grabb M.C.; Zipfel G.J.; Choi D.W.; Brain tissue responses to ischemia. J Clin Invest 2000,106(6),723-731","journal-title":"J Clin Invest"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1046\/j.1471-4159.2003.01756.x","volume":"85","author":"Zhao H.","year":"2003","unstructured":"Zhao H.; Yenari M.A.; Cheng D.; Sapolsky R.M.; Steinberg G.K.; Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem 2003,85(4),1026-1036","journal-title":"J Neurochem"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1038\/sj.emboj.7601253","volume":"25","author":"Barsoum M.J.","year":"2006","unstructured":"Barsoum M.J.; Yuan H.; Gerencser A.A.; Liot G.; Kushnareva Y.; Gr\u00e4ber S.; Kovacs I.; Lee W.D.; Waggoner J.; Cui J.; White A.D.; Bossy B.; Martinou J.C.; Youle R.J.; Lipton S.A.; Ellisman M.H.; Perkins G.A.; Bossy-Wetzel E.; Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 2006,25(16),3900-3911","journal-title":"EMBO J"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/cdd.2012.18","volume":"19","author":"Grohm J.","year":"2012","unstructured":"Grohm J.; Kim S-W.; Mamrak U.; Tobaben S.; Cassidy-Stone A.; Nunnari J.; Plesnila N.; Culmsee C.; Inhibition of Drp1 provides neuroprotection in vitro and in vivo. Cell Death Differ 2012,19(9),1446-1458","journal-title":"Cell Death Differ"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.3390\/ijms15034453","volume":"15","author":"Zhang L.","year":"2014","unstructured":"Zhang L.; He Z.; Zhang Q.; Wu Y.; Yang X.; Niu W.; Hu Y.; Jia J.; Exercise pretreatment promotes mitochondrial dynamic protein OPA1 expression after cerebral ischemia in rats. Int J Mol Sci 2014,15(3),4453-4463","journal-title":"Int J Mol Sci"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1007\/s12035-022-02795-6","volume":"59","author":"Song M.","year":"2022","unstructured":"Song M.; Zhou Y.; Fan X.; Mitochondrial quality and quantity control: mitophagy is a potential therapeutic target for ischemic stroke. Mol Neurobiol 2022,59(5),3110-3123","journal-title":"Mol Neurobiol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2119\/molmed.2015.00038","volume":"21","author":"Di Y.","year":"2015","unstructured":"Di Y.; He Y.L.; Zhao T.; Huang X.; Wu K.W.; Liu S.H.; Zhao Y.Q.; Fan M.; Wu L.Y.; Zhu L.L.; Methylene blue reduces acute cerebral ischemic injury via the induction of mitophagy. Mol Med 2015,21(1),420-429","journal-title":"Mol Med"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"755665","DOI":"10.3389\/fnagi.2021.755665","volume":"13","author":"Liang J.","year":"2021","unstructured":"Liang J.; Wang C.; Zhang H.; Huang J.; Xie J.; Chen N.; Exercise-induced benefits for Alzheimer\u2019s disease by stimulating mitophagy and improving mitochondrial function. Front Aging Neurosci 2021,13,755665","journal-title":"Front Aging Neurosci"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.freeradbiomed.2016.11.045","volume":"102","author":"Raefsky S.M.","year":"2017","unstructured":"Raefsky S.M.; Mattson M.P.; Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance. Free Radic Biol Med 2017,102,203-216","journal-title":"Free Radic Biol Med"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/npp.2010.32","volume":"35","author":"Escribano L.","year":"2010","unstructured":"Escribano L.; Sim\u00f3n A.M.; Gimeno E.; Cuadrado-Tejedor M.; L\u00f3pez de Maturana R.; Garc\u00eda-Osta A.; Ricobaraza A.; P\u00e9rez-Mediavilla A.; Del R\u00edo J.; Frechilla D.; Rosiglitazone rescues memory impairment in Alzheimer\u2019s transgenic mice: mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology 2010,35(7),1593-1604","journal-title":"Neuropsychopharmacology"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3233\/JAD-2012-111661","volume":"30","author":"Searcy J.L.","year":"2012","unstructured":"Searcy J.L.; Phelps J.T.; Pancani T.; Kadish I.; Popovic J.; Anderson K.L.; Beckett T.L.; Murphy M.P.; Chen K.C.; Blalock E.M.; Landfield P.W.; Porter N.M.; Thibault O.; Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 2012,30(4),943-961","journal-title":"J Alzheimers Dis"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-016-0090-7","volume":"11","author":"Pinto M.","year":"2016","unstructured":"Pinto M.; Nissanka N.; Peralta S.; Brambilla R.; Diaz F.; Moraes C.T.; Pioglitazone ameliorates the phenotype of a novel Parkinson\u2019s disease mouse model by reducing neuroinflammation. Mol Neurodegener 2016,11(1),25","journal-title":"Mol Neurodegener"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00109-021-02065-3","volume":"99","author":"Zhao Y.","year":"2021","unstructured":"Zhao Y.; L\u00fctzen U.; Gohlke P.; Jiang P.; Herdegen T.; Culman J.; Neuroprotective and antioxidative effects of pioglitazone in brain tissue adjacent to the ischemic core are mediated by PI3K\/Akt and Nrf2\/ARE pathways. J Mol Med (Berl) 2021,99(8),1073-1083","journal-title":"J Mol Med (Berl)"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1471-4159.2006.03758.x","volume":"97","author":"Luo Y.","year":"2006","unstructured":"Luo Y.; Yin W.; Signore A.P.; Zhang F.; Hong Z.; Wang S.; Graham S.H.; Chen J.; Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-\u03b3 agonist rosiglitazone. J Neurochem 2006,97(2),435-448","journal-title":"J Neurochem"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(15)00144-1","volume":"14","year":"2015","unstructured":"Pioglitazone in early Parkinson\u2019s disease: a phase 2, multicentre, double-blind, randomised trial. Lancet Neurol 2015,14(8),795-803","journal-title":"Lancet Neurol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","volume":"6","author":"Risner M.E.","year":"2006","unstructured":"Risner M.E.; Saunders A.M.; Altman J F B.; Ormandy G.C.; Craft S.; Foley I.M.; Zvartau-Hind M.E.; Hosford D.A.; Roses A.D.; Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer\u2019s disease. Pharmacogenomics J 2006,6(4),246-254","journal-title":"Pharmacogenomics J"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","volume":"71","author":"Beal M.F.","year":"2014","unstructured":"Beal M.F.; Oakes D.; Shoulson I.; Henchcliffe C.; Galpern W.R.; Haas R.; Juncos J.L.; Nutt J.G.; Voss T.S.; Ravina B.; Shults C.M.; Helles K.; Snively V.; Lew M.F.; Griebner B.; Watts A.; Gao S.; Pourcher E.; Bond L.; Kompoliti K.; Agarwal P.; Sia C.; Jog M.; Cole L.; Sultana M.; Kurlan R.; Richard I.; Deeley C.; Waters C.H.; Figueroa A.; Arkun A.; Brodsky M.; Ondo W.G.; Hunter C.B.; Jimenez-Shahed J.; Palao A.; Miyasaki J.M.; So J.; Tetrud J.; Reys L.; Smith K.; Singer C.; Blenke A.; Russell D.S.; Cotto C.; Friedman J.H.; Lannon M.; Zhang L.; Drasby E.; Kumar R.; Subramanian T.; Ford D.S.; Grimes D.A.; Cote D.; Conway J.; Siderowf A.D.; Evatt M.L.; Sommerfeld B.; Lieberman A.N.; Okun M.S.; Rodriguez R.L.; Merritt S.; Swartz C.L.; Martin W.R.W.; King P.; Stover N.; Guthrie S.; Watts R.L.; Ahmed A.; Fernandez H.H.; Winters A.; Mari Z.; Dawson T.M.; Dunlop B.; Feigin A.S.; Shannon B.; Nirenberg M.J.; Ogg M.; Ellias S.A.; Thomas C.A.; Frei K.; Bodis-Wollner I.; Glazman S.; Mayer T.; Hauser R.A.; Pahwa R.; Langhammer A.; Ranawaya R.; Derwent L.; Sethi K.D.; Farrow B.; Prakash R.; Litvan I.; Robinson A.; Sahay A.; Gartner M.; Hinson V.K.; Markind S.; Pelikan M.; Perlmutter J.S.; Hartlein J.; Molho E.; Evans S.; Adler C.H.; Duffy A.; Lind M.; Elmer L.; Davis K.; Spears J.; Wilson S.; Leehey M.A.; Hermanowicz N.; Niswonger S.; Shill H.A.; Obradov S.; Rajput A.; Cowper M.; Lessig S.; Song D.; Fontaine D.; Zadikoff C.; Williams K.; Blindauer K.A.; Bergholte J.; Propsom C.S.; Stacy M.A.; Field J.; Mihaila D.; Chilton M.; Uc E.Y.; Sieren J.; Simon D.K.; Kraics L.; Silver A.; Boyd J.T.; Hamill R.W.; Ingvoldstad C.; Young J.; Thomas K.; Kostyk S.K.; Wojcieszek J.; Pfeiffer R.F.; Panisset M.; Beland M.; Reich S.G.; Cines M.; Zappala N.; Rivest J.; Zweig R.; Lumina L.P.; Hilliard C.L.; Grill S.; Kellermann M.; Tuite P.; Rolandelli S.; Kang U.J.; Young J.; Rao J.; Cook M.M.; Severt L.; Boyar K.; A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol 2014,71(5),543-552","journal-title":"JAMA Neurol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.bbadis.2018.05.018","volume":"1864","author":"Xi Y.","year":"2018","unstructured":"Xi Y.; Feng D.; Tao K.; Wang R.; Shi Y.; Qin H.; Murphy M.P.; Yang Q.; Zhao G.; MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1\u03b1. Biochim Biophys Acta Mol Basis Dis 2018,1864(9)(9 Pt B),2859-2870","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11481-016-9650-4","volume":"11","author":"Ghosh A.","year":"2016","unstructured":"Ghosh A.; Langley M.R.; Harischandra D.S.; Neal M.L.; Jin H.; Anantharam V.; Joseph J.; Brenza T.; Narasimhan B.; Kanthasamy A.; Kalyanaraman B.; Kanthasamy A.G.; Mitoapocynin treatment protects against neuroinflammation and dopaminergic neurodegeneration in a preclinical animal model of Parkinson\u2019s Disease. J Neuroimmune Pharmacol 2016,11(2),259-278","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"S609","DOI":"10.3233\/JAD-2010-100564","volume":"20","author":"Manczak M.","year":"2010","unstructured":"Manczak M.; Mao P.; Calkins M.J.; Cornea A.; Reddy A.P.; Murphy M.P.; Szeto H.H.; Park B.; Reddy P.H.; Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer\u2019s disease neurons. J Alzheimers Dis 2010,20(s2)(Suppl. 2),S609-S631","journal-title":"J Alzheimers Dis"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.3390\/molecules23081871","volume":"23","author":"Silachev D.","year":"2018","unstructured":"Silachev D.; Plotnikov E.; Pevzner I.; Zorova L.; Balakireva A.; Gulyaev M.; Pirogov Y.; Skulachev V.; Zorov D.; Neuroprotective effects of mitochondria-targeted plastoquinone in a rat model of neonatal hypoxic\u2013ischemic brain injury. Molecules 2018,23(8),1871","journal-title":"Molecules"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/mds.23148","volume":"25","author":"Snow B.J.","year":"2010","unstructured":"Snow B.J.; Rolfe F.L.; Lockhart M.M.; Frampton C.M.; O\u2019Sullivan J.D.; Fung V.; Smith R.A.J.; Murphy M.P.; Taylor K.M.; A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson\u2019s disease. Mov Disord 2010,25(11),1670-1674","journal-title":"Mov Disord"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMoa070240","volume":"357","author":"Shuaib A.","year":"2007","unstructured":"Shuaib A.; Lees K.R.; Lyden P.; Grotta J.; Davalos A.; Davis S.M.; Diener H.C.; Ashwood T.; Wasiewski W.W.; Emeribe U.; NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 2007,357(6),562-571","journal-title":"N Engl J Med"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"47284","DOI":"10.18632\/oncotarget.17618","volume":"8","author":"Wang Q.M.","year":"2017","unstructured":"Wang Q.M.; Xu Y.Y.; Liu S.; Ma Z.G.; Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice. Oncotarget 2017,8(29),47284-47295","journal-title":"Oncotarget"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/jnc.12038","volume":"123","author":"Gong L.","year":"2012","unstructured":"Gong L.; Zhang Q.L.; Zhang N.; Hua W.Y.; Huang Y.X.; Di P.W.; Huang T.; Xu X.S.; Liu C.F.; Hu L.F.; Luo W.F.; Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson\u2019s disease: Linking to Akt\/GSK3\u03b2 signaling pathway. J Neurochem 2012,123(5),876-885","journal-title":"J Neurochem"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1523\/JNEUROSCI.2385-16.2017","volume":"37","author":"Baek S.H.","year":"2017","unstructured":"Baek S.H.; Park S.J.; Jeong J.I.; Kim S.H.; Han J.; Kyung J.W.; Baik S.H.; Choi Y.; Choi B.Y.; Park J.S.; Bahn G.; Shin J.H.; Jo D.S.; Lee J.Y.; Jang C.G.; Arumugam T.V.; Kim J.; Han J.W.; Koh J.Y.; Cho D.H.; Jo D.G.; Inhibition of Drp1 ameliorates synaptic depression, A\u03b2 deposition, and cognitive impairment in an Alzheimer\u2019s Disease model. J Neurosci 2017,37(20),5099-5110","journal-title":"J Neurosci"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"32656","DOI":"10.1038\/srep32656","volume":"6","author":"Filichia E.","year":"2016","unstructured":"Filichia E.; Hoffer B.; Qi X.; Luo Y.; Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson\u2019s disease model induced by MPTP. Sci Rep 2016,6(1),32656","journal-title":"Sci Rep"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1523\/JNEUROSCI.1926-19.2020","volume":"40","author":"Flippo K.H.","year":"2020","unstructured":"Flippo K.H.; Lin Z.; Dickey A.S.; Zhou X.; Dhanesha N.A.; Walters G.C.; Liu Y.; Merrill R.A.; Meller R.; Simon R.P.; Chauhan A.K.; Usachev Y.M.; Strack S.; Deletion of a neuronal Drp1 activator protects against cerebral ischemia. J Neurosci 2020,40(15),3119-3129","journal-title":"J Neurosci"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2174\/138945011795528813","volume":"12","author":"Santos R.X.","year":"2011","unstructured":"Santos R.X.; Correia S.C.; Carvalho C.; Cardoso S.; Santos M.S.; Moreira P.I.; Mitophagy in neurodegeneration: An opportunity for therapy? Curr Drug Targets 2011,12(6),790-799","journal-title":"Curr Drug Targets"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12974-021-02334-5","volume":"18","author":"Zhang L.","year":"2021","unstructured":"Zhang L.; Dai L.; Li D.; Mitophagy in neurological disorders. J Neuroinflammation 2021,18(1),297","journal-title":"J Neuroinflammation"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3390\/cells10071827","volume":"10","author":"Nascimento-dos-Santos G.","year":"2021","unstructured":"Nascimento-dos-Santos G.; de-Souza-Ferreira E.; Linden R.; Galina A.; Petrs-Silva H.; Mitotherapy: Unraveling a promising treatment for disorders of the central nervous system and other systemic conditions. Cells 2021,10(7),1827","journal-title":"Cells"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"672781","DOI":"10.3389\/fonc.2021.672781","volume":"11","author":"Qin Y.","year":"2021","unstructured":"Qin Y.; Jiang X.; Yang Q.; Zhao J.; Zhou Q.; Zhou Y.; The functions, methods, and mobility of mitochondrial transfer between cells. Front Oncol 2021,11,672781","journal-title":"Front Oncol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/stem.2372","volume":"34","author":"Jackson M.V.","year":"2016","unstructured":"Jackson M.V.; Morrison T.J.; Doherty D.F.; McAuley D.F.; Matthay M.A.; Kissenpfennig A.; O\u2019Kane C.M.; Krasnodembskaya A.D.; Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS. Stem Cells 2016,34(8),2210-2223","journal-title":"Stem Cells"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"e2467","DOI":"10.1038\/cddis.2016.358","volume":"7","author":"Jiang D.","year":"2016","unstructured":"Jiang D.; Gao F.; Zhang Y.; Wong D.S.H.; Li Q.; Tse H.; Xu G.; Yu Z.; Lian Q.; Mitochondrial transfer of mesenchymal stem cells effectively protects corneal epithelial cells from mitochondrial damage. Cell Death Dis 2016,7(11),e2467","journal-title":"Cell Death Dis"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nm.2736","volume":"18","author":"Islam M.N.","year":"2012","unstructured":"Islam M.N.; Das S.R.; Emin M.T.; Wei M.; Sun L.; Westphalen K.; Rowlands D.J.; Quadri S.K.; Bhattacharya S.; Bhattacharya J.; Mitochondrial transfer from bone-marrow\u2013derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 2012,18(5),759-765","journal-title":"Nat Med"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nature18928","volume":"535","author":"Hayakawa K.","year":"2016","unstructured":"Hayakawa K.; Esposito E.; Wang X.; Terasaki Y.; Liu Y.; Xing C.; Ji X.; Lo E.H.; Transfer of mitochondria from astrocytes to neurons after stroke. Nature 2016,535(7613),551-555","journal-title":"Nature"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10549-012-2283-2","volume":"136","author":"Elliott R.L.","year":"2012","unstructured":"Elliott R.L.; Jiang X.P.; Head J.F.; Mitochondria organelle transplantation: introduction of normal epithelial mitochondria into human cancer cells inhibits proliferation and increases drug sensitivity. Breast Cancer Res Treat 2012,136(2),347-354","journal-title":"Breast Cancer Res Treat"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.healun.2018.09.025","volume":"38","author":"Moskowitzova K.","year":"2019","unstructured":"Moskowitzova K.; Shin B.; Liu K.; Ramirez-Barbieri G.; Guariento A.; Blitzer D.; Thedsanamoorthy J.K.; Yao R.; Snay E.R.; Inkster J.A.H.; Orfany A.; Zurakowski D.; Cowan D.B.; Packard A.B.; Visner G.A.; del Nido P.J.; McCully J.D.; Mitochondrial transplantation prolongs cold ischemia time in murine heart transplantation. J Heart Lung Transplant 2019,38(1),92-99","journal-title":"J Heart Lung Transplant"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12967-021-02878-3","volume":"19","author":"Hayashida K.","year":"2021","unstructured":"Hayashida K.; Takegawa R.; Shoaib M.; Aoki T.; Choudhary R.C.; Kuschner C.E.; Nishikimi M.; Miyara S.J.; Rolston D.M.; Guevara S.; Kim J.; Shinozaki K.; Molmenti E.P.; Becker L.B.; Mitochondrial transplantation therapy for ischemia reperfusion injury: A systematic review of animal and human studies. J Transl Med 2021,19(1),214","journal-title":"J Transl Med"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jtcvs.2020.10.151","volume":"162","author":"Guariento A.","year":"2021","unstructured":"Guariento A.; Piekarski B.L.; Doulamis I.P.; Blitzer D.; Ferraro A.M.; Harrild D.M.; Zurakowski D.; del Nido P.J.; McCully J.D.; Emani S.M.; Autologous mitochondrial transplantation for cardiogenic shock in pediatric patients following ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2021,162(3),992-1001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/ejcts\/ezz326","volume":"57","author":"Doulamis I.P.","year":"2020","unstructured":"Doulamis I.P.; Guariento A.; Duignan T.; Orfany A.; Kido T.; Zurakowski D.; del Nido P.J.; McCully J.D.; Mitochondrial transplantation for myocardial protection in diabetic hearts. Eur J Cardiothorac Surg 2020,57(5),836-845","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/schbul\/sbx077","volume":"44","author":"Robicsek O.","year":"2018","unstructured":"Robicsek O.; Ene H.M.; Karry R.; Ytzhaki O.; Asor E.; McPhie D.; Cohen B.M.; Ben-Yehuda R.; Weiner I.; Ben-Shachar D.; Isolated mitochondria transfer improves neuronal differentiation of schizophrenia-derived induced pluripotent stem cells and rescues deficits in a rat model of the disorder. Schizophr Bull 2018,44(2),432-442","journal-title":"Schizophr Bull"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/295605a0","volume":"295","author":"Clark M.A.","year":"1982","unstructured":"Clark M.A.; Shay J.W.; Mitochondrial transformation of mammalian cells. Nature 1982,295(5850),605-607","journal-title":"Nature"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1073\/pnas.1404651111","volume":"111","author":"Davis C.O.","year":"2014","unstructured":"Davis C.O.; Kim K.Y.; Bushong E.A.; Mills E.A.; Boassa D.; Shih T.; Kinebuchi M.; Phan S.; Zhou Y.; Bihlmeyer N.A.; Nguyen J.V.; Jin Y.; Ellisman M.H.; Marsh-Armstrong N.; Transcellular degradation of axonal mitochondria. Proc Natl Acad Sci USA 2014,111(26),9633-9638","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1074\/mcp.M500298-MCP200","volume":"5","author":"Forner F.","year":"2006","unstructured":"Forner F.; Foster L.J.; Campanaro S.; Valle G.; Mann M.; Quantitative proteomic comparison of rat mitochondria from muscle, heart, and liver. Mol Cell Proteomics 2006,5(4),608-619","journal-title":"Mol Cell Proteomics"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"C383","DOI":"10.1152\/ajpcell.1993.264.2.C383","volume":"264","author":"Cogswell A.M.","year":"1993","unstructured":"Cogswell A.M.; Stevens R.J.; Hood D.A.; Properties of skeletal muscle mitochondria isolated from subsarcolemmal and intermyofibrillar regions. Am J Physiol Cell Physiol 1993,264(2),C383-C389","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"e51682","DOI":"10.3791\/51682","author":"Preble J.M.","year":"2014","unstructured":"Preble J.M.; Pacak C.A.; Kondo H.; MacKay A.A.; Cowan D.B.; McCully J.D.; Rapid isolation and purification of mitochondria for transplantation by tissue dissociation and differential filtration. J Vis Exp 2014(91),e51682","journal-title":"J Vis Exp"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.trsl.2015.12.003","volume":"170","author":"Chang J.C.","year":"2016","unstructured":"Chang J.C.; Wu S.L.; Liu K.H.; Chen Y.H.; Chuang C.S.; Cheng F.C.; Su H.L.; Wei Y.H.; Kuo S.J.; Liu C.S.; Allogeneic\/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson\u2019s disease: Restoration of mitochondria functions and attenuation of 6-hydroxydopamine\u2013induced neurotoxicity. Transl Res 2016,170,40-56.e3","journal-title":"Transl Res"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneumeth.2017.05.023","volume":"287","author":"Gollihue J.L.","year":"2017","unstructured":"Gollihue J.L.; Patel S.P.; Mashburn C.; Eldahan K.C.; Sullivan P.G.; Rabchevsky A.G.; Optimization of mitochondrial isolation techniques for intraspinal transplantation procedures. J Neurosci Methods 2017,287,1-12","journal-title":"J Neurosci Methods"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"H966","DOI":"10.1152\/ajpheart.00883.2012","volume":"304","author":"Masuzawa A.","year":"2013","unstructured":"Masuzawa A.; Black K.M.; Pacak C.A.; Ericsson M.; Barnett R.J.; Drumm C.; Seth P.; Bloch D.B.; Levitsky S.; Cowan D.B.; McCully J.D.; Transplantation of autologously derived mitochondria protects the heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2013,304(7),H966-H982","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mito.2018.03.002","volume":"46","author":"Ramirez-Barbieri G.","year":"2019","unstructured":"Ramirez-Barbieri G.; Moskowitzova K.; Shin B.; Blitzer D.; Orfany A.; Guariento A.; Iken K.; Friehs I.; Zurakowski D.; del Nido P.J.; McCully J.D.; Alloreactivity and allorecognition of syngeneic and allogeneic mitochondria. Mitochondrion 2019,46,103-115","journal-title":"Mitochondrion"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"e121622","DOI":"10.1172\/jci.insight.121622","volume":"3","author":"Pollara J.","year":"2018","unstructured":"Pollara J.; Edwards R.W.; Lin L.; Bendersky V.A.; Brennan T.V.; Circulating mitochondria in deceased organ donors are associated with immune activation and early allograft dysfunction. JCI Insight 2018,3(15),e121622","journal-title":"JCI Insight"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.it.2011.01.005","volume":"32","author":"Krysko D.V.","year":"2011","unstructured":"Krysko D.V.; Agostinis P.; Krysko O.; Garg A.D.; Bachert C.; Lambrecht B.N.; Vandenabeele P.; Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011,32(4),157-164","journal-title":"Trends Immunol"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1161\/CIRCRESAHA.119.316291","volume":"126","author":"Bertero E.","year":"2020","unstructured":"Bertero E.; O\u2019Rourke B.; Maack C.; Mitochondria do not survive calcium overload during transplantation. Circ Res 2020,126(6),784-786","journal-title":"Circ Res"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1096\/fj.201901917RR","volume":"34","author":"Al Amir Dache Z.","year":"2020","unstructured":"Al Amir Dache Z.; Otandault A.; Tanos R.; Pastor B.; Meddeb R.; Sanchez C.; Arena G.; Lasorsa L.; Bennett A.; Grange T.; El Messaoudi S.; Mazard T.; Prevostel C.; Thierry A.R.; Blood contains circulating cell\u2010free respiratory competent mitochondria. FASEB J 2020,34(3),3616-3630","journal-title":"FASEB J"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"10710","DOI":"10.1038\/s41598-017-10870-5","volume":"7","author":"Chang J.C.","year":"2017","unstructured":"Chang J.C.; Hoel F.; Liu K.H.; Wei Y.H.; Cheng F.C.; Kuo S.J.; Tronstad K.J.; Liu C.S.; Peptide-mediated delivery of donor mitochondria improves mitochondrial function and cell viability in human cybrid cells with the MELAS A3243G mutation. Sci Rep 2017,7(1),10710","journal-title":"Sci Rep"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"1700530","DOI":"10.1002\/advs.201700530","volume":"5","author":"Wu S.","year":"2018","unstructured":"Wu S.; Zhang A.; Li S.; Chatterjee S.; Qi R.; Segura-Ibarra V.; Ferrari M.; Gupte A.; Blanco E.; Hamilton D.J.; Polymer functionalization of isolated mitochondria for cellular transplantation and metabolic phenotype alteration. Adv Sci (Weinh) 2018,5(3),1700530","journal-title":"Adv Sci (Weinh)"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12951-020-00748-6","volume":"19","author":"Picone P.","year":"2021","unstructured":"Picone P.; Porcelli G.; Bavisotto C.C.; Nuzzo D.; Galizzi G.; Biagio P.L.S.; Bulone D.; Di Carlo M.; Synaptosomes: New vesicles for neuronal mitochondrial transplantation. J Nanobiotechnology 2021,19(1),6","journal-title":"J Nanobiotechnology"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.healun.2020.06.023","volume":"39","author":"Guariento A.","year":"2020","unstructured":"Guariento A.; Doulamis I.P.; Duignan T.; Kido T.; Regan W.L.; Saeed M.Y.; Hoganson D.M.; Emani S.M.; Fynn-Thompson F.; Matte G.S.; del Nido P.J.; McCully J.D.; Mitochondrial transplantation for myocardial protection in ex-situ\u2012perfused hearts donated after circulatory death. J Heart Lung Transplant 2020,39(11),1279-1288","journal-title":"J Heart Lung Transplant"},{"key":"ref=181","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-02937-w","author":"Adlimoghaddam A.","year":"2022","unstructured":"Adlimoghaddam A.; Benson T.; Albensi B.C.; Mitochondrial transfusion improves mitochondrial function through up-regulation of mitochondrial complex II protein subunit SDHB in the hippocampus of aged mice. Mol Neurobiol [Epublished of print].2022","journal-title":"Mol Neurobiol"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/15353702211056866","volume":"247","author":"Bobkova N.V.","year":"2022","unstructured":"Bobkova N.V.; Zhdanova D.Y.; Belosludtseva N.V.; Penkov N.V.; Mironova G.D.; Intranasal administration of mitochondria improves spatial memory in olfactory bulbectomized mice. Exp Biol Med (Maywood) 2022,247(5),416-425","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1161\/STROKEAHA.120.030152","volume":"51","author":"Nakamura Y.","year":"2020","unstructured":"Nakamura Y.; Lo E.H.; Hayakawa K.; Placental mitochondria therapy for cerebral ischemia-reperfusion injury in mice. Stroke 2020,51(10),3142-3146","journal-title":"Stroke"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.brainresbull.2020.09.018","volume":"165","author":"Pourmohammadi-Bejarpasi Z.","year":"2020","unstructured":"Pourmohammadi-Bejarpasi Z.; Roushandeh A.M.; Saberi A.; Rostami M.K.; Toosi S.M.R.; Jahanian-Najafabadi A.; Tomita K.; Kuwahara Y.; Sato T.; Roudkenar M.H.; Mesenchymal stem cells-derived mitochondria transplantation mitigates I\/R-induced injury, abolishes I\/R-induced apoptosis, and restores motor function in acute ischemia stroke rat model. Brain Res Bull 2020,165,70-80","journal-title":"Brain Res Bull"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3727\/096368915X689785","volume":"25","author":"Huang P.J.","year":"2016","unstructured":"Huang P.J.; Kuo C.C.; Lee H.C.; Shen C.I.; Cheng F.C.; Wu S.F.; Chang J.C.; Pan H.C.; Lin S.Z.; Liu C.S.; Su H.L.; Transferring Xenogenic mitochondria provides neural protection against ischemic stress in ischemic rat brains. Cell Transplant 2016,25(5),913-927","journal-title":"Cell Transplant"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/1006636","volume":"2021","author":"Xie Q.","year":"2021","unstructured":"Xie Q.; Zeng J.; Zheng Y.; Li T.; Ren J.; Chen K.; Zhang Q.; Xie R.; Xu F.; Zhu J.; Mitochondrial transplantation attenuates cerebral ischemia-reperfusion injury: Possible involvement of mitochondrial component separation. Oxid Med Cell Longev 2021,2021,1-21","journal-title":"Oxid Med Cell Longev"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X05666220908100545","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208641\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X05666220908100545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T00:27:20Z","timestamp":1693700840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208641\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":186,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x05666220908100545","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}